These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30684965)

  • 1. Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial.
    Thota RN; Acharya SH; Garg ML
    Lipids Health Dis; 2019 Jan; 18(1):31. PubMed ID: 30684965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHA-enriched fish oil reduces insulin resistance in overweight and obese adults.
    Abbott KA; Burrows TL; Acharya S; Thota RN; Garg ML
    Prostaglandins Leukot Essent Fatty Acids; 2020 Aug; 159():102154. PubMed ID: 32563863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial.
    Thota RN; Acharya SH; Abbott KA; Garg ML
    Trials; 2016 Nov; 17(1):565. PubMed ID: 27894336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study.
    Austin G; Ferguson JJ; Thota RN; Singh H; Burrows T; Garg ML
    Clin Nutr; 2021 Feb; 40(2):420-427. PubMed ID: 32684486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial.
    O'Mahoney LL; Dunseath G; Churm R; Holmes M; Boesch C; Stavropoulos-Kalinoglou A; Ajjan RA; Birch KM; Orsi NM; Mappa G; Price OJ; Campbell MD
    Cardiovasc Diabetol; 2020 Aug; 19(1):127. PubMed ID: 32787879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
    Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
    Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults.
    Munro IA; Garg ML
    Obes Res Clin Pract; 2013; 7(3):e173-81. PubMed ID: 23697585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
    Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
    Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma phospholipid omega-3 polyunsaturated fatty acids and type 2 diabetes is sex dependent: The Hunter Community Study.
    Abbott KA; Burrows TL; Thota RN; Alex A; Acharya S; Attia J; McEvoy M; Garg ML
    Clin Nutr; 2020 Apr; 39(4):1059-1066. PubMed ID: 31023487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the omega 3 index of healthy subjects does not alter the effects of dietary saturated fats or n-6PUFA on LDL profiles.
    Dias CB; Amigó N; Wood LG; Mallol R; Correig X; Garg ML
    Metabolism; 2017 Mar; 68():11-19. PubMed ID: 28183443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes.
    Thota RN; Ferguson JJA; Abbott KA; Dias CB; Garg ML
    Food Funct; 2018 Jul; 9(7):3576-3596. PubMed ID: 29904777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial.
    Clark LF; Thivierge MC; Kidd CA; McGeoch SC; Abraham P; Pearson DW; Horgan GW; Holtrop G; Thies F; Lobley GE
    Br J Nutr; 2016 Jan; 115(1):75-86. PubMed ID: 26537735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
    Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
    J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    Brown TJ; Brainard J; Song F; Wang X; Abdelhamid A; Hooper L;
    BMJ; 2019 Aug; 366():l4697. PubMed ID: 31434641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.
    O'Mahoney LL; Matu J; Price OJ; Birch KM; Ajjan RA; Farrar D; Tapp R; West DJ; Deighton K; Campbell MD
    Cardiovasc Diabetol; 2018 Jul; 17(1):98. PubMed ID: 29981570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.
    Ferguson JJA; Stojanovski E; MacDonald-Wicks L; Garg ML
    Metabolism; 2018 May; 82():22-35. PubMed ID: 29291429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes.
    Jamilian M; Samimi M; Ebrahimi FA; Hashemi T; Taghizadeh M; Razavi M; Sanami M; Asemi Z
    J Clin Lipidol; 2017; 11(2):459-468. PubMed ID: 28502503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids.
    Dias CB; Wood LG; Garg ML
    Eur J Clin Nutr; 2016 Jul; 70(7):812-8. PubMed ID: 26757835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.